tm logo
Trademark Search
STYLIZED TRIANGLE DESIGN
STYLIZED TRIANGLE DESIGN
REGISTERED

on 18 May 2022

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2005239 filed on 21st Nov 2019

Registration Number

TMA1129079 registered on 18th May 2022

Registration expiry Date

14th Nov 2027

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

STYLIZED TRIANGLE DESIGN

Vienna Information


26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 3 . 6

Triangular figures with one or more convex or concave sidesFigures triangulaires à un ou plusieurs côtés convexes ou concaves

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 7 . 18

Triangles with linesTriangles avec lignes

26 . 11 . 1

One line or one bandUne ligne ou une bande

29 . 1 . 4

BlueBleu

29 . 1 . 5

VioletViolet

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; antiinflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical antifungals


Classification kind code

11

Mark Details


Serial Number

2005239

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 09th Nov 2021
Agent Changed
Submitted for opposition 22
on 30th Apr 2021
Search Recorded
Submitted for opposition 20
on 30th Apr 2021
Examiner's First Report
Submitted for opposition 223
on 30th Apr 2021
Total Provisional Refusal
Submitted for opposition 256
on 09th Nov 2020
Notification of Possible Opposition Sent
Submitted for opposition 257
on 09th Jan 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 08th Jan 2020
Created
Submitted for opposition 31
on 08th Jan 2020
Formalized
Submitted for opposition 30
on 21st Nov 2019
Filed
Submitted for opposition 228
on 14th Nov 2017
International Registration